SDS

SAFETY DATA SHEET-
FRSM5075 2-CYCLE ENGINE OIL
10.3.1. Avoid strong oxidants
10.4. Possibility of Hazardous Reactions:
10.4.1. Will not undergo hazardous polymerization.
10.5. Hazardous Decomposition Products:
10.5.1. Partial burning produces fumes, smoke and carbon monoxide
11. TOXICOLOGY INFORMATION
11.1. Likely Routes of Exposure:
11.1.1. Ingestion, Inhalation, Eye contact, Skin contact.
11.2. Acute Effects:
11.2.1. Inhalation: Aspiration hazard. May cause respiratory irritation.
11.2.2. Eye Contact: Causes eye irritation.
11.2.3. Causes skin irritation.
11.2.4. Ingestion: Expected to be low ingestion hazard.
11.3. Component Data/ Analysis
11.3.1. Petroleum naptha:
11.3.1.1. Oral (LD50) (Rat): Acute: >5000 mg/kg
11.3.1.2. Inhalation (LC50) (Rat): Acute: >5.2 mg/l (4hr)
11.3.1.3. Dermal (LD50) (Rabbit): >2000 mg/kg
11.3.2. Residual oils (petroleum), solvent refined:
11.3.2.1. Oral (LD50) (Rat): Acute: >5000 mg/kg
11.3.2.2. Inhalation (LC50) (Rat): Acute: 8.72 mg/l (4hr)
11.3.2.3. Dermal (LD50) (Rabbit): 2000-5000 mg/kg
11.3.3. Solvent-dewaxed heavy paraffinic distillates:
11.3.3.1. Oral (LD50) (Rat): Acute: >5000 mg/kg
11.3.3.2. Inhalation (LC50) (Rat): Acute: 2.18 mg/l (4hr)
11.3.3.3. Dermal (LD50) (Rabbit): >2000 mg/kg
11.3.4. Distillates (petroleum), hydrotreated light:
11.3.3.1. Oral (LD50) (Rat): Acute: >15000 mg/kg
11.3.3.2. Inhalation (LC50) (Rat): Acute: 5.2 mg/l (4hr)
11.3.3.3. Dermal (LD50) (Rabbit): >2000 mg/kg
11.4. Sensitization:
11.4.1. Based on best current information, there are no known human effects.
11.5. Carcinogenicity:
11.5.1. There is no known information on carcinogenic components.
11.6. Mutagenicity:
11.6.1. Not expected to be mutagenicity.
11.7. Reproductive Toxicity:
11.7.1. Based on best current information, there are no known human effects.
11.8. Teratogenicity:
11.8.1. Based on best current information, there are no known human effects.
12. ECOLOGICAL INFORMATION
Page 6 of 8